Blue Bird
BLBD
55.84
-1.35
-2.35%
Blue Bird
US · BLBD
#2870 by market cap
Listed 1970
55.84
-1.35
-2.35%
Live - 5344 symbols - heartbeat 454s ago
· 2026-10-08 03:13
After-hours
55.84
0.00%
Overnight
55.67
-0.30%
- Market cap
- 1.90B
- P/E (TTM)i
- 6.61
- P/Bi
- 2.90
- EPSi
- 3.88
- Div yieldi
- 0.00%
- 52W posi
- 26%
Reader sentiment
Are you bullish or bearish on BLBD?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.87, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +9.87% YoY
Margins
- Gross margin
- 20.51%
- Operating margin
- 11.29%
- Net margin
- 8.63%
Key ratios & quality
- Enterprise valuei
- 1.76B
- Altman Z-Scorei
- 6.87
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.02B | 1.02B | 879.22M | 684.00M | 800.64M | 1.13B | 1.35B | 1.48B |
| Gross profit | 121.99M | 133.47M | 96.20M | 72.14M | 36.55M | 138.85M | 256.16M | 303.51M |
| Selling & admin expenses | 86.91M | 89.64M | 74.21M | 65.62M | 77.25M | 87.19M | 116.83M | 136.35M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 35.08M | 43.83M | 21.99M | 6.52M | -40.70M | 51.66M | 139.33M | 167.17M |
| Pretax profit | 26.87M | 29.63M | 10.49M | -1.98M | -53.05M | 25.81M | 126.94M | 169.56M |
| Tax | -2.62M | 7.57M | 1.52M | -1.19M | -11.45M | 8.95M | 33.23M | 43.93M |
| Net profit | 30.82M | 24.30M | 12.19M | -289.00K | -45.76M | 23.81M | 105.55M | 127.72M |
| Basic EPS | 1 | 1 | 0 | 0 | -1 | 1 | 3 | 4 |
| Diluted EPS | 1.08 | 0.90 | 0.45 | -0.01 | -1.48 | 0.74 | 3.16 | 3.88 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 358.85M | 398.01M | 409.37M | 333.08M | 352.64M | 517.16M |
| Gross profit | 70.85M | 85.93M | 86.41M | 71.23M | 70.65M | 103.37M |
| Selling & admin expenses | 37.14M | 35.86M | 36.07M | 33.55M | 31.53M | 40.71M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 33.71M | 50.07M | 50.34M | 37.68M | 39.12M | 62.67M |
| Pretax profit | 33.60M | 49.23M | 51.12M | 37.88M | 36.58M | 197.02M |
| Tax | 9.13M | 12.38M | 13.73M | 9.12M | 9.10M | 10.17M |
| Net profit | 26.05M | 36.46M | 36.50M | 30.76M | 29.30M | 185.26M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 5 |
| Diluted EPS | 0.79 | 1.12 | 1.11 | 0.94 | 0.90 | 5.27 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 149.84M | 172.09M | 116.90M | 156.07M | 174.48M | 236.06M | 323.38M | 411.63M |
| Cash & ST investments | 60.26M | 70.96M | 44.51M | 11.71M | 10.48M | 78.99M | 127.69M | 229.31M |
| Inventory | 57.33M | 78.83M | 56.52M | 125.21M | 142.98M | 135.29M | 127.80M | 139.47M |
| Total assets | 307.43M | 365.41M | 317.42M | 356.02M | 366.13M | 417.77M | 524.89M | 625.26M |
| Total current liabilities | 148.86M | 169.68M | 111.65M | 124.78M | 164.77M | 229.62M | 235.97M | 236.80M |
| Short-term debt | 9.90M | 10.62M | 11.18M | 16.18M | 20.37M | 20.38M | 5.98M | 5.00M |
| Long-term debt | 132.24M | 173.23M | 164.20M | 194.57M | 150.39M | 110.54M | 89.99M | 85.32M |
| Total liabilities | 335,766,000.00 | 433,224,000.00 | 370,645,000.00 | 388,676,000.00 | 364,744,000.00 | 377,768,000.00 | 365,330,000.00 | 369,840,000.00 |
| Total equity | -28.34M | -67.81M | -53.23M | -32.66M | 1.38M | 40.00M | 159.56M | 255.42M |
| Retained earnings | -69.24M | -45.65M | -33.46M | -33.75M | -79.51M | -55.70M | 0 | 88.19M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 328.42M | 360.67M | 411.63M | 425.78M | 466.57M | 513.71M |
| Cash & ST investments | 130.75M | 173.07M | 229.31M | 241.74M | 275.89M | 116.82M |
| Inventory | 163.83M | 151.04M | 139.47M | 140.93M | 144.77M | 302.47M |
| Total assets | 543.70M | 575.45M | 625.26M | 642.34M | 689.36M | 1.17B |
| Total current liabilities | 226.65M | 228.58M | 236.80M | 235.11M | 254.28M | 313.35M |
| Short-term debt | 5.38M | 5.00M | 5.00M | 5.00M | 5.00M | 5.98M |
| Long-term debt | 87.66M | 86.49M | 85.32M | 84.15M | 82.98M | 81.81M |
| Total liabilities | 353,306,000.00 | 353,603,000.00 | 369,840,000.00 | 370,974,000.00 | 391,436,000.00 | 511,628,000.00 |
| Total equity | 190.39M | 221.85M | 255.42M | 271.37M | 297.93M | 654.89M |
| Retained earnings | 24.72M | 52.23M | 88.19M | 103.99M | 128.30M | 313.56M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 48.35M | 55.71M | 3.46M | -54.24M | -24.44M | 119.93M | 111.11M | 176.21M |
| Depreciation & amortization | 9.04M | 10.38M | 14.40M | 13.45M | 14.05M | 15.98M | 14.82M | 15.59M |
| Free cash flow | 16.24M | 20.19M | -15.51M | -66.45M | -30.89M | 111.41M | 95.85M | 153.34M |
| Dividends paid | -1.90M | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -26.59M | -50.37M | 0 | -517.00K | 73.29M | -376.00K | -11.12M | -49.42M |
| Ending cash balance | 60.26M | 70.96M | 44.51M | 11.71M | 10.48M | 78.99M | 127.69M | 229.31M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 27.77M | 56.92M | 65.12M | 36.58M | 47.76M | 31.04M |
| Depreciation & amortization | 3.85M | 3.96M | 3.92M | 3.98M | 4.07M | 8.75M |
| Free cash flow | 18.75M | 52.32M | 60.46M | 31.11M | 39.91M | 21.66M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -22.98M | -4.53M | -10.42M | -17.34M | -5.19M | 2.57M |
| Ending cash balance | 130.75M | 173.07M | 229.31M | 241.74M | 275.89M | 116.82M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | 115.09 | 105.78 | 61.55 |
| ROA %i | 9.59 | 7.22 | 3.57 | -0.09 | -12.67 | 6.08 | 22.39 | 22.21 |
| ROIC %i | -- | -- | -- | -- | -- | 20.21 | 51.61 | 42.73 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.27 | 4.17 | 2.59 | 1.13 | -4.79 | 3.87 | 10.21 | 11.94 |
| FCF / sales %i | 1.58 | 1.98 | -- | -- | -- | 9.83 | 7.11 | 10.36 |
| Current ratioi | 1.01 | 1.01 | 1.05 | 1.25 | 1.06 | 1.03 | 1.37 | 1.74 |
| Quick ratioi | 0.57 | 0.48 | 0.47 | 0.17 | 0.14 | 0.40 | 0.79 | 1.06 |
| Debt / assetsi | 46.23 | 51.38 | 57.11 | 60.47 | 47.07 | 31.58 | 18.28 | 14.45 |
| LT debt / equityi | -- | -- | -- | -- | 10,995.95 | 278.84 | 56.40 | 33.41 |
| Interest coveragei | 5.03 | 3.30 | 1.86 | 0.80 | -2.62 | 2.43 | 13.00 | 24.54 |
| Revenue CAGR (3Y) %i | 3.70 | 3.01 | -3.90 | -12.61 | -7.72 | 8.81 | 25.35 | 22.73 |
| Net income CAGR (3Y) %i | 27.32 | 52.14 | -24.93 | -- | -- | 25.02 | -- | -- |
| FCF CAGR (3Y) %i | -3.69 | 9.16 | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 73.02 | 64.54 | 61.55 | 57.53 | 54.48 | 64.29 |
| ROA %i | 21.62 | 22.21 | 22.21 | 22.04 | 21.57 | 32.36 |
| ROIC %i | 45.26 | 42.89 | 42.73 | 40.96 | 39.59 | 52.06 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 10.25 | 10.70 | 11.94 | 11.92 | 12.15 | 20.43 |
| FCF / sales %i | 6.44 | 10.07 | 10.36 | 10.85 | 12.31 | 9.50 |
| Current ratioi | 1.45 | 1.58 | 1.74 | 1.81 | 1.83 | 1.64 |
| Quick ratioi | 0.65 | 0.85 | 1.06 | 1.07 | 1.14 | 0.54 |
| Debt / assetsi | 17.11 | 15.90 | 14.45 | 13.88 | 12.76 | 9.92 |
| LT debt / equityi | 46.04 | 38.99 | 33.41 | 31.01 | 27.85 | 16.76 |
| Interest coveragei | 17.68 | 20.28 | 24.54 | 26.07 | 27.55 | 48.36 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Bus is the largest reported line at 95.08% of revenue, across 2 reported segments.
- The next-largest line, Parts, is a distant second at 4.92% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Bus95.08%
Parts4.92%
Quote time 2026-10-08 03:13:59 · For reference only, not investment advice and not tailored to your situation.